SESAUA 2024: Darolutamide in Combination with ADT and Docetaxel: Efficacy and Safety by Disease Volume and Risk in the Phase 3 ARASENS Trial – UroToday
SESAUA 2024: Darolutamide in Combination with ADT and Docetaxel: Efficacy and Safety by Disease Volume and Risk in the Phase 3 ARASENS Trial UroToday
Source: Technology News Feed